Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments

ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT

L. E. Böttiger, G Boman, Gustav Eklund et al. · The Lancet · 1980 · 398 citations

Medicine, Gynecology, Obstetrics +14

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

G. Tolis, DCF ACKMAN, A. Stellos et al. · Proceedings of the National Academy of Sciences · 1982 · 368 citations · Full text

Medicine, Endocrinology, Urology +14

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Tommie W. Redding, Andrew V. Schally · Proceedings of the National Academy of Sciences · 1981 · 153 citations · Full text

Medicine, Oncology, Pharmacology +17

TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER

JanG.M. Klijn, FrankH. De Jong · The Lancet · 1982 · 147 citations

Medicine, Oncology, Pharmacology +12

Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing Hormone

Jürgen Sandow, W. von Rechenberg, G. Jerzabek et al. · Fertility and Sterility · 1978 · 140 citations

Medicine, Endocrinology, Pharmacology +16